Table 1

Current performance in the diagnosis and treatment of 100 patients with chlamydia and 100 patients with gonorrhoea infections

Treated at initial visitReasons for treatment at initial visitTime from test to result for untreated patients in calendar days*Time from test to treatment for initially untreated patients in calendar daysNumber of untreated patients after >3 monthsPatients with extra-genital infection only
Patients with chlamydia infection
 Female15/52 29%13 CT contact
1 GC contact
1 NSU contact
Median 5 (3–9)Median 7 (4–36)01 Pharyngeal
1 Rectal
 Male29/48 60%16 Urethritis
8 CT contact
2 GC
2 epididymitis
1 GC contact
Median 4 (2–7)Median 6.5 (3–14)21 Rectal
 Total44/100 44%Median 5 (2–9)Median 7 (3–36)23
Chlamydia tests done over the same periodNumber of TestsProportion Chlamydia +veNumber of PatientsPrevalence of chlamydia
844 M5.7%780 M6.2%
993 F5.2%930 F5.6%
1837 T5.4%1710 T5.8%
Patients with gonorrhoea infection
 Female12/33 36%10 GC contact
2 Microscopy
Median 5 (3–9)Median 7 (4–28)13 Pharyngeal
 Male42/67 63%35 Microscopy
7 GC contact
Median 5 (3–9)Median 7 (4–14)08 Pharyngeal
6 Rectal
3 both
 Total54/100 54%Median 5 (3–9)Median 5 (4–28)120
Number of gonorrhoea tests in same periodNumber of TestsProportion GC+veNumber of patientsPrevalence of GC
2144 M3.1% M1792M3.7% M
2431 F1.4% F2003 F1.6% F
4575 T2.2% Total3795 Total2.6% Total
  • *3–4 working days (equal to 5 calendar days when weekends/holidays included).

  • CT, Chlamydia trachomatis; F, female; GC, gonorrhoea; M, male; NSU, non-specific urethritis; T, total.